LifeMD, Inc.
LFMD
$3.90
-$0.19-4.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 754.17% | 12.95% | 17.69% | 48.83% | -87.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 754.17% | 12.95% | 17.69% | 48.83% | -87.77% |
| Cost of Revenue | -11.42% | 47.76% | 47.88% | 87.90% | 27.01% |
| Gross Profit | 3,205.70% | 9.34% | 14.45% | 44.28% | -103.33% |
| SG&A Expenses | 1,175.41% | 3.02% | 6.82% | 19.68% | -92.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 50.94% | 43.93% | 58.57% | 1.42% | 38.18% |
| Total Operating Expenses | 318.70% | 8.51% | 12.35% | 25.52% | -75.64% |
| Operating Income | 81.61% | 50.72% | 52.64% | 141.21% | -174.88% |
| Income Before Tax | 83.68% | 25.63% | 44.07% | 128.83% | -135.37% |
| Income Tax Expenses | -96.20% | -27.27% | -- | -- | -14.60% |
| Earnings from Continuing Operations | 84.33% | 25.71% | 44.07% | 128.83% | -115.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 106.64% | -292.66% | -104.41% | -345.39% | 38.83% |
| Net Income | 504.24% | 18.29% | 36.79% | 120.46% | -32.33% |
| EBIT | 81.61% | 50.72% | 52.64% | 141.21% | -174.88% |
| EBITDA | 88.00% | 60.07% | 59.78% | 150.35% | -249.91% |
| EPS Basic | 403.85% | 23.20% | 36.69% | 107.33% | -10.02% |
| Normalized Basic EPS | 86.80% | 44.98% | 37.53% | 114.14% | -71.50% |
| EPS Diluted | 392.78% | 23.08% | 37.27% | 105.20% | -11.30% |
| Normalized Diluted EPS | 86.80% | 44.98% | 37.53% | 113.41% | -71.50% |
| Average Basic Shares Outstanding | 13.54% | 9.86% | 7.55% | 9.92% | 12.12% |
| Average Diluted Shares Outstanding | 13.54% | 9.86% | 7.55% | 16.15% | 12.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 1.27% | -0.22% | -0.58% | 5.89% | 0.30% |